Skip to content

Profiling of Post Covid-19 Infection Patients: an Online Survey

Profiling of Post Covid-19 Infection Patients: an Online Survey

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04912778
Acronym
PRESTO
Enrollment
567
Registered
2021-06-03
Start date
2021-06-04
Completion date
2021-08-30
Last updated
2021-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

The aim of this study is to explore the relation between indicators of central sensitisation, quality of life and functional status in patients post covid-19 infection.

Interventions

Patients are asked to fill in an online survey regarding functional status, quality of life and symptoms of central sensitisation.

Sponsors

STIMULUS research group, Vrije Universiteit Brussel
CollaboratorUNKNOWN
Moens Maarten
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* male and female adults who were previously infected with covid-19

Design outcomes

Primary

MeasureTime frameDescription
Functional statusUp to 18 months after infection with Covid-19.Post-COVID-19 functional status is evaluated by the Post-COVID-19 Functional Status Scale.
Health-related Quality of lifeUp to 18 months after infection with Covid-19.The EuroQol with five dimensions and three levels is used to evaluate health-related quality of life.
Symptoms of central sensitisationUp to 18 months after infection with Covid-19.Symptoms of central sensitisation are assessed by the Central Sensitization Inventory.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026